- Products & Services
- Knowledge Base
WOBURN, MA, August 04, 2020 /24-7PressRelease/ -- Modular Genetics is a chemical company. The company designs and produces microbial strains that synthesize valuable chemicals via fermentation. Modular's patented bio-engineering technology simplifies gene engineering such that it can be accomplished with robots and computer systems.
With this platform, the company created another, higher-level, platform, which enables the production of specialty chemicals (surfactants) via fermentation. Modular is a green chemistry company that produces surfactants, which are certified as both palm and crude oil free.
Modular is developing additional platforms, which will be used to develop other classes of chemicals—beyond surfactants.
The OCMX™ is pleased to announce the listing of Modular Genetics, Inc. to its online portal which offers Investors and Advisors the ability to participate in this opportunity.
The OCMX™ has spent considerable time completing its due diligence on Modular Genetics, Inc. and concluded that there is indeed a tremendous opportunity for Investors and Advisors.
The OCMX™ noted that Modular Genetics, Inc. exhibits the main components of any solid investment opportunity, namely a solid management team, a great track record, and a number of key competitive advantages.
1. Sustainable manufacturing is the future of manufacturing
Modular is a leading company developing methods for manufacturing the renewable chemicals that will replace chemicals manufactured from petroleum and palm oil—a market greater than $150 billion.
2. Demonstrated ability to invent and secure patent protection
Intellectual property is valuable and will enable Modular to defend its technology and products from the competition.
3. Customer attraction
Large international customers will purchase Modular's surfactants and other chemicals.
Kevin Jarrell, PhD, Chief Executive Officer
Dr. Kevin Jarrell is the founder and Chief Executive Officer of Modular Genetics. Inventor of the company's patent portfolio and nationally recognized expert on biotechnology.
He served on the National Bio-Defense Safety Council for the Secretary of Health and Human Services. In his academic career at Harvard University, Boston University, and Ohio State University, his research resulted in numerous publications and contributed significantly to the current understanding of how living organisms manipulate their genetic information.
Of specific interest are the limitations associated with the current genetic engineering tools available to the scientist as well as the emergence of high-throughput technologies aimed at increasing the size and diversity of genetic libraries under study through the use of automation and efficient design. In addition, Dr. Jarrell's work has resulted in seven U.S. issued patents and twenty six pending applications.
Terry Brennan, Chief Financial Officer
Terry is a finance & operations executive with experience in the chemical, private equity and venture capital markets. He holds P&L responsibility and manage all financial and administrative functions.
He has previously worked with Private Equity firms and Venture Capital funds like JPB Enterprises, Community Technology Fund and Watermill Ventures, where he reviewed deals for determination of indication of interest. Completed purchase of a corporate divestiture in thin film coating, and managed nine early stage portfolio companies in Medical Devices, Drug Discovery and Biotechnology.
He also has worked with KPMG and Ernst and Young as a Senior Manager, where he focused on transactions, restructurings and performance improvement with Private Equity and mid to large strategic clients. Earned corporate bonus rewarded to top 10% of performers.
He attended Northeastern University for his, MA – MBA and Ecole Superieure de Commerce; Reims, France for International MBA Program.
Tim Dummer, EVP Business Development
Experienced global business leader and innovator with proven record of results in delivering revenue and profit growth for Fortune100 and start-up companies. Expertise in strategy, business development, strategic partnerships, sales & marketing, and international operations. Strategic and tactical thinker with demonstrated success in creating and implementing breakthrough strategies. Accomplished at articulating a vision and aligning personnel and processes to achieve goals. Took businesses from concept to commercialization. Transformed and grew established businesses. Managed entire product life cycles. Demonstrated abilities to identify, evaluate and commercialize innovative technologies.
Tim has built cross-functional teams to develop and grow new businesses with annual revenues of $250+M. Transformed business and grew global sales pipeline from $50M to $350M in 12 months. Commercialized 10+ world 1st technologies – biotechnology, chemicals/materials, advanced transportation. Led team to successfully integrate acquisition in 9 months, improving annual profitability $7.5M.
He hold International Business Management from INSEAD Business School, Singapore & France and Bachelor of Engineering (honors) in Chemical Engineering, University of Bradford, England among other management programs he has attended.
ABOUT THE OCMX™
The OCMX™ is literally changing how companies and investment funds generate exposure in the marketplace and raise funds as we know it. The OCMX™ serves both public and private companies along with investment and mutual funds which need to raise additional funds or gain significant market exposure. It does this by way of connecting the relevant companies, funds, investors, and advisors all in one online transparent portal. The OCMX™ (P2P Financial Inc.) launched in September of 2009 out of Toronto but has since expanded its operations to include Quebec, Alberta, Manitoba, and British Columbia.
The OCMX™ connects investors and advisors directly with companies and investment funds seeking to raise funds or gain broad market exposure. The OCMX™ provides an open venue for innovative growth companies and leading investment funds to generate market awareness, raise funds, or connect with investors and advisors. The OCMX™ provides companies, funds, investors, and advisors instant access to its Online Portal so that they can actively source and connect with their next opportunity, advisor, investor, client, or financing partner.
TD Canada Trust Tower
161 Bay Street, 45th Floor
Toronto, Ontario, M5J 2S1
Email: [email protected]
# # #